Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/31220
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorLEE, Dong Hoon
dc.contributor.authorREZENDE, Leandro Fornias Machado de
dc.contributor.authorHU, Frank B.
dc.contributor.authorJEON, Justin Y.
dc.contributor.authorGIOVANNUCCI, Edward L.
dc.date.accessioned2019-03-26T14:31:54Z-
dc.date.available2019-03-26T14:31:54Z-
dc.date.issued2019
dc.identifier.citationDIABETES-METABOLISM RESEARCH AND REVIEWS, v.35, n.2, article ID e3095, 9p, 2019
dc.identifier.issn1520-7560
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31220-
dc.description.abstractBackground Positive association between resting heart rate (RHR) and risk of type 2 diabetes (T2D) has been documented in several studies. However, whether RHR is an independent predictor of T2D and its potential interaction with other risk factors of T2D remain unclear. Methods We conducted a prospective cohort study of 31 156 men from the Health Professionals Follow-up Study (1992-2012). Cox proportional hazard model was used to examine the association between RHR and T2D risk. We further examined whether this association is modified by known risk factors. Lastly, we conducted a meta-analysis of prospective cohort studies. Results During 505 380 person-years of follow-up, we identified 2338 incident T2D cases. The multivariable-adjusted hazard ratio (HR) comparing the highest vs lowest categories of RHR was 1.69 (95% confidence interval [CI], 1.43-2.01). Increase in 10 bpm of RHR was associated with 19% increased risk of T2D in the fully adjusted model (HR, 1.19; 95% CI, 1.14-1.24). The HRs of T2D associated with RHR were stronger among those with normal weight or without hypertension (P interaction < 0.001). Moreover, RHR with other known risk factors cumulatively increased T2D risk. A meta-analysis consistently showed a positive association between RHR and T2D risk (the summary relative risk [RR] for highest vs lowest RHR, 1.53; 95% CI, 1.26-1.86, n = 12, the summary RR per 10 bpm increase, 1.17; 95% CI, 1.09-1.26, n = 13). Conclusions High RHR was independently associated with increased risk of T2D. Our findings suggest that RHR, with other known risk factors, could be a useful tool to predict T2D risk.eng
dc.description.sponsorshipNational Institutes of Health [UM1 CA167552, R01 HL35464]
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2014/25614-4, 2016/21390-0]
dc.language.isoeng
dc.publisherWILEYeng
dc.relation.ispartofDiabetes-Metabolism Research and Reviews
dc.rightsrestrictedAccesseng
dc.subjectinteractioneng
dc.subjectmeta-analysiseng
dc.subjectprospective cohorteng
dc.subjectresting heart rateeng
dc.subjectrisk factoreng
dc.subjecttype 2 diabeteseng
dc.subject.othernervous-system functioneng
dc.subject.otherall-cause mortalityeng
dc.subject.otherphysical-fitnesseng
dc.subject.otherlife-styleeng
dc.subject.othermeneng
dc.subject.otherclassificationeng
dc.subject.otherinterventioneng
dc.subject.otherdeterminantseng
dc.subject.otherpopulationeng
dc.subject.otherdiagnosiseng
dc.titleResting heart rate and risk of type 2 diabetes: A prospective cohort study and meta-analysiseng
dc.typearticleeng
dc.rights.holderCopyright WILEYeng
dc.identifier.doi10.1002/dmrr.3095
dc.identifier.pmid30378246
dc.subject.wosEndocrinology & Metabolismeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalLEE, Dong Hoon:Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2,3rd Floor, Boston, MA 02115 USA
hcfmusp.author.externalHU, Frank B.:Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2,3rd Floor, Boston, MA 02115 USA; Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA
hcfmusp.author.externalJEON, Justin Y.:Yonsei Univ, Dept Sport Ind Studies, Exercise Med & Rehabil Lab, Seoul, South Korea; Yonsei Univ, Coll Med, ICONS, Exercise Med Ctr Diabet & Canc Patients, Seoul, South Korea
hcfmusp.author.externalGIOVANNUCCI, Edward L.:Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bldg 2,3rd Floor, Boston, MA 02115 USA; Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA
hcfmusp.description.articlenumbere3095
hcfmusp.description.issue2
hcfmusp.description.volume35
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000457591100009
hcfmusp.origem.id2-s2.0-85056769553
hcfmusp.publisher.cityHOBOKENeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAmer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011eng
hcfmusp.relation.reference[Anonymous], 2017, NAT DIAB STAT REPeng
hcfmusp.relation.referenceArdisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345eng
hcfmusp.relation.referenceAune D, 2015, NUTR METAB CARDIOVAS, V25, P526, DOI 10.1016/j.numecd.2015.02.008eng
hcfmusp.relation.referenceAune D, 2017, NUTR METABOLISM CARDeng
hcfmusp.relation.referenceBLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395eng
hcfmusp.relation.referenceBohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016eng
hcfmusp.relation.referenceCarnethon MR, 2008, DIABETES CARE, V31, P335, DOI 10.2337/dc07-0874eng
hcfmusp.relation.referenceCarnethon MR, 2006, DIABETES CARE, V29, P914, DOI 10.2337/diacare.29.04.06.dc05-1729eng
hcfmusp.relation.referenceCarnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95eng
hcfmusp.relation.referenceFESKENS EJM, 1989, AM J EPIDEMIOL, V130, P1101, DOI 10.1093/oxfordjournals.aje.a115437eng
hcfmusp.relation.referenceFox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-Xeng
hcfmusp.relation.referenceGavin JR, 1997, DIABETES CARE, V20, P1183eng
hcfmusp.relation.referenceGrantham NM, 2013, DIABETIC MED, V30, P421, DOI 10.1111/dme.12045eng
hcfmusp.relation.referenceHARRIS M, 1979, DIABETES, V28, P1039eng
hcfmusp.relation.referenceJae SY, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.01.014eng
hcfmusp.relation.referenceJensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375eng
hcfmusp.relation.referenceJulius S, 1992, Blood Press, V1, P9, DOI 10.3109/08037059209065119eng
hcfmusp.relation.referenceKima'b G, 2017, DIABETES METAB, V43, P25, DOI 10.1016/j.diabet.2016.09.002eng
hcfmusp.relation.referenceKnowler WC, 2002, NEW ENGL J MED, V346, P393eng
hcfmusp.relation.referenceLahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038eng
hcfmusp.relation.referenceLee DH, 2016, BREAST CANCER RES TR, V159, P375, DOI 10.1007/s10549-016-3938-1eng
hcfmusp.relation.referenceLee MK, 2018, CLIN CHIMICA ACTAeng
hcfmusp.relation.referenceMathur MBDP, 2018, EPIDEMIOLOGYeng
hcfmusp.relation.referenceNagaya T, 2010, INT J EPIDEMIOL, V39, P215, DOI 10.1093/ije/dyp229eng
hcfmusp.relation.referencePalatini P, 2006, DRUGS, V66, P133, DOI 10.2165/00003495-200666020-00001eng
hcfmusp.relation.referencePalatini P, 1999, AM J HYPERTENS, V12, p3S, DOI 10.1016/S0895-7061(98)00207-6eng
hcfmusp.relation.referencePark J, 1932, RESTING HEART RATE Ieng
hcfmusp.relation.referencePerin PC, 2001, CLIN EXP HYPERTENS, V23, P45, DOI 10.1081/CEH-100001196eng
hcfmusp.relation.referencePERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560eng
hcfmusp.relation.referenceRogowski O, 2007, HEART, V93, P940, DOI 10.1136/hrt.2006.101949eng
hcfmusp.relation.referenceSajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003eng
hcfmusp.relation.referenceSANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803eng
hcfmusp.relation.referenceShigetoh Y, 2009, AM J HYPERTENS, V22, P151, DOI 10.1038/ajh.2008.331eng
hcfmusp.relation.referenceSzklo M, 2014, EPIDEMIOLOGY BASICSeng
hcfmusp.relation.referenceVanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607eng
hcfmusp.relation.referenceWang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0eng
hcfmusp.relation.referenceWang L, 2015, INT J EPIDEMIOL, V44, P689, DOI 10.1093/ije/dyv079eng
hcfmusp.relation.referenceWorld Health Organization, 2016, GLOB REP DIABeng
hcfmusp.relation.referenceYamaguchi J, 2005, AM J HYPERTENS, V18, P1218, DOI 10.1016/j.amjhyper.2005.04.009eng
hcfmusp.relation.referenceYang HI, 1873, ASS RESTING HEART RAeng
hcfmusp.relation.referenceZhang J, 1999, EUR HEART J, V20, P103, DOI 10.1053/euhj.1999.1230eng
hcfmusp.relation.referenceZhang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23939eng
hcfmusp.relation.referenceZhang XL, 2010, INT J EPIDEMIOL, V39, P900, DOI 10.1093/ije/dyq068eng
dc.description.indexMEDLINEeng
hcfmusp.citation.scopus17-
hcfmusp.scopus.lastupdate2022-07-15-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/Outros
Outros departamentos - FM/Outros

Artigos e Materiais de Revistas Científicas - LIM/38
LIM/38 - Laboratório de Epidemiologia e Imunobiologia

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_LEE_Resting_heart_rate_and_risk_of_type_2_2019.PDF
  Restricted Access
publishedVersion (English)267.63 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.